Biohaven Ltd.
public_traded
Biohaven Ltd. is publicly traded on NYSE under ticker BHVN.
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.